Charleston Neuroscience Center
Charleston, South Carolina, United States
Medical clinic in Charleston, South Carolina
3531 Mary Ader Ave, Charleston, SC 29414
About Charleston Neuroscience Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Charleston Neuroscience Center
During the past decade, Charleston Neuroscience Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2017-12-05
2020-10-06
Terminated
279
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
2018-07-17
2020-08-18
Terminated
34
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Charleston Neuroscience Center"
#1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Charleston Neuroscience Center
According to Clinical.Site data, the most researched conditions in "Charleston Neuroscience Center" are
"Neovascular Age-Related Macular Degeneration" (1 trials) and "Non-proliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Charleston Neuroscience Center" in a lesser frequency.
Clinical Trials Intervention Types at Charleston Neuroscience Center
Most popular intervention types in "Charleston Neuroscience Center" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials), "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials), "KSI-301" (1 trials) and "Sham injection" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Charleston Neuroscience Center
The vast majority of trials in "Charleston Neuroscience Center" are
2 trials for "All" genders.
Clinical Trials Status at Charleston Neuroscience Center
Currently, there are NaN active trials in "Charleston Neuroscience Center".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Charleston Neuroscience Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Charleston Neuroscience Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".